Percutaneous treatment of aortic valve stenosis

Cleveland Clinic Journal of Medicine

Volumn 75, Issue 11, 2008, Pages 805-812

  Singh, Inder M ^a   Shishehbor, Mehdi H ^a   Christofferson, Ryan D ^a   Tuzcu, E Murat ^a   Kapadia, Samir R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE; AORTA VALVE STENOSIS; BALLOON DILATATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; INSTRUMENTATION; METHODOLOGY; PATHOLOGY; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; AORTIC VALVE; AORTIC VALVE STENOSIS; BALLOON DILATATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS;

EID: 58149477328     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.75.11.805     Document Type: Review

References (46)

1. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114:e84-231.
2. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111:3316-3326.
3. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24:1231-1243.
4. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368:1005-1011.
5. Goodney PP, O'Connor GT, Wennberg DE, Birkmeyer JD. Do hospitals with low mortality rates in coronary artery bypass also perform well in valve replacement? Ann Thorac Surg 2003; 76:1131-1137.
6. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1986; 1:63-67.
7. Vahanian A, Palacios IF. Percutaneous approaches to valvular disease. Circulation 2004; 109:1572-1579.
8. Webb JG, Munt B, Makkar RR, Naqvi TZ, Dang N. Percutaneous stent-mounted valve for treatment of aortic or pulmonary valve disease. Catheter Cardiovasc Interv 2004; 63:89-93.
9. Alexander KP, Anstrom KJ, Muhlbaier LH, et al. Outcomes of cardiac surgery in patients ≥80 years: results from the National Cardiovascular Network. J Am Coll Cardiol 2000; 35:731-738.
10. Mittermair RP, Muller LC. Quality of life after cardiac surgery in the elderly. J Cardiovasc Surg (Torino) 2002; 43:43-47.
11. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116:755-763.
12. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005; 26:2714-2720.
13. Bonhoeffer P, Boudjemilne Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000; 356:1403-1405.
14. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992; 13:704-708.
15. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106:3006-3008.
16. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 1994; 89:642-650.
17. Safian RD, Berman AD, Diver DJ, et al. Balloon aortic valvuloplasty in 170 consecutive patients. N Engl J Med 1988; 319:125-130.
18. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation 1991; 84:2383-2397.
19. Safian RD, Mandell VS, Thurer RE, et al. Postmortem and intraoperative balloon valvuloplasty of calcific aortic stenosis in elderly patients: mechanisms of successful dilation. J Am Coll Cardiol 1987; 9:655-660.
20. Agarwal A, Kini AS, Attanti S, et al. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol 2005; 95:43-47.
21. Kapadia SR, Wazni OM, Tan WA, et al. Aortic valvuloplasty in 1990's: experience from a single center in United States. Circulation 1999; 100(18 suppl 1):1-448.
22. Lieberman EB, Bashore TM, Hermiller JB, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J Am Coll Cardiol 1995; 26:1522-1528.
23. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the french experience. J Am Coll Cardiol 2006; 47:1214-1223.
24. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004; 43:698-703.
25. Rajagopal V, Kapadia SR, Tuzcu EM. Advances in the percutaneous treatment of aortic and mitral valve disease. Minerva Cardioangiol 2007; 55:83-94.
26. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006; 113:842-850.
27. Salemi A. Percutaneous valve interventions. Curr Opin Anaesthesiol 2007; 20:70-74.
28. Grube E, Laborde JC, Gerkens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006; 114:1616-1624.
29. Grube E, Laborde JC, Zickmann B, et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv 2005; 66:465-469.
30. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients wing the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007; 50:69-76.
31. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006; 114:591-596.
32. Walther T, Falk V, Borger MA, et al. Minimally invasive transapical beating heart aortic valve implantation - proof of concept. Eur J Cardiothorac Surg 2007; 31:9-15.
33. Ye J, Cheung A, Lichtenstein SV, et al. Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg 2007; 31:16-21.
34. Turgut T, Deeb M, Moscucci M. Left ventricular apical puncture: a procedure surviving well into the new millennium. Catheter Cardiovasc Interv 2000; 49:68-73.
35. Zuguchi M, Shindoh C, Chida K, et al. Safety and clinical benefits of transsubxiphoidal left ventricular puncture. Cathether Cardiovasc Interv 2002; 55:58-65.
36. Sinha AK, Kini AS, Sharma SK. Percutaneous valve replacement: a paradigm shift. Curr Opin Cardiol 2007; 22:471-477.
37. Wenaweser P, Buellesfeld L, Gerckens U, Grube E. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the CoreValve ReValving system. Catheter Cardiovasc Interv 2007; 70:760-764.
38. Pasupati S, Humphries K, AIAli A, et al. Balloon expandable aortic valve (BEAV) implantation. The first 100 canadian patients. Circulation 2007 116(suppl):357.
39. Walther T, Falk V, Kempfert J, et al. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg 2008; 33:983-988. Epub 2008 February 21.
40. Carabello BA. Clinical practice. Aortic stenosis. N Engl J Med 2002; 346:677-682.
41. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990; 15:1012-1017.
42. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968; 38:61-67.
43. Kvidal P, Bergstrom R, Horte LG, Stahle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000; 35:747-758.
44. Society of Thoracic Surgeons National Cardiac Surgery Database. Available at www.sts.org/documents/pdf/ Spring2005STS-ExecutiveSummary.pdf. Accessed 9/11/2008.
45. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346:1128-1137.
46. Wenger NK, Weber MA, Scheidt S. Valvular heart disease at elderly age: new vistas. Am J Geriatr Cardiol 2006; 15:273-274.